637 related articles for article (PubMed ID: 10490961)
1. Modulating dendritic cells to optimize mucosal immunization protocols.
Williamson E; Westrich GM; Viney JL
J Immunol; 1999 Oct; 163(7):3668-75. PubMed ID: 10490961
[TBL] [Abstract][Full Text] [Related]
2. CD11c(high )dendritic cells are essential for activation of CD4+ T cells and generation of specific antibodies following mucosal immunization.
Fahlén-Yrlid L; Gustafsson T; Westlund J; Holmberg A; Strömbeck A; Blomquist M; MacPherson GG; Holmgren J; Yrlid U
J Immunol; 2009 Oct; 183(8):5032-41. PubMed ID: 19786541
[TBL] [Abstract][Full Text] [Related]
3. Expanding dendritic cells in vivo enhances the induction of oral tolerance.
Viney JL; Mowat AM; O'Malley JM; Williamson E; Fanger NA
J Immunol; 1998 Jun; 160(12):5815-25. PubMed ID: 9637492
[TBL] [Abstract][Full Text] [Related]
4. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
Huibregtse IL; Snoeck V; de Creus A; Braat H; De Jong EC; Van Deventer SJ; Rottiers P
Gastroenterology; 2007 Aug; 133(2):517-28. PubMed ID: 17681173
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells and immune responses to orally administered antigens.
Mowat AM
Vaccine; 2005 Mar; 23(15):1797-9. PubMed ID: 15734044
[TBL] [Abstract][Full Text] [Related]
6. IL-10 and IL-27 producing dendritic cells capable of enhancing IL-10 production of T cells are induced in oral tolerance.
Shiokawa A; Tanabe K; Tsuji NM; Sato R; Hachimura S
Immunol Lett; 2009 Jun; 125(1):7-14. PubMed ID: 19446579
[TBL] [Abstract][Full Text] [Related]
7. Oral tolerance revisited: prior oral tolerization abrogates cholera toxin-induced mucosal IgA responses.
Kato H; Fujihashi K; Kato R; Yuki Y; McGhee JR
J Immunol; 2001 Mar; 166(5):3114-21. PubMed ID: 11207263
[TBL] [Abstract][Full Text] [Related]
8. IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacter felis infection.
Bromander AK; Ekman L; Kopf M; Nedrud JG; Lycke NY
J Immunol; 1996 Jun; 156(11):4290-7. PubMed ID: 8666800
[TBL] [Abstract][Full Text] [Related]
9. Orally administered OVA/CpG-ODN induces specific mucosal and systemic immune response in young and aged mice.
Alignani D; Maletto B; Liscovsky M; Rópolo A; Morón G; Pistoresi-Palencia MC
J Leukoc Biol; 2005 Jun; 77(6):898-905. PubMed ID: 15758079
[TBL] [Abstract][Full Text] [Related]
10. Functional maturation of lamina propria dendritic cells by activation of NKT cells mediates the abrogation of oral tolerance.
Chang JH; Lee JM; Youn HJ; Lee KA; Chung Y; Lee AY; Kweon MN; Kim HY; Taniguchi M; Kang CY
Eur J Immunol; 2008 Oct; 38(10):2727-39. PubMed ID: 18825753
[TBL] [Abstract][Full Text] [Related]
11. Regulation of mucosal dendritic cell function by receptor activator of NF-kappa B (RANK)/RANK ligand interactions: impact on tolerance induction.
Williamson E; Bilsborough JM; Viney JL
J Immunol; 2002 Oct; 169(7):3606-12. PubMed ID: 12244151
[TBL] [Abstract][Full Text] [Related]
12. Sublingual immunization induces broad-based systemic and mucosal immune responses in mice.
Cuburu N; Kweon MN; Song JH; Hervouet C; Luci C; Sun JB; Hofman P; Holmgren J; Anjuère F; Czerkinsky C
Vaccine; 2007 Dec; 25(51):8598-610. PubMed ID: 17996991
[TBL] [Abstract][Full Text] [Related]
13. Cholera holotoxin and its B subunit enhance Peyer's patch B cell responses induced by orally administered influenza virus: disproportionate cholera toxin enhancement of the IgA B cell response.
Chen KS; Strober W
Eur J Immunol; 1990 Feb; 20(2):433-6. PubMed ID: 2311649
[TBL] [Abstract][Full Text] [Related]
14. Immunization with wild-type p53 gene sequences coadministered with Flt3 ligand induces an antigen-specific type 1 T-cell response.
Parajuli P; Pisarev V; Sublet J; Steffel A; Varney M; Singh R; LaFace D; Talmadge JE
Cancer Res; 2001 Nov; 61(22):8227-34. PubMed ID: 11719454
[TBL] [Abstract][Full Text] [Related]
15. Non-toxic Stx derivatives from Escherichia coli possess adjuvant activity for mucosal immunity.
Ohmura-Hoshino M; Yamamoto M; Yuki Y; Takeda Y; Kiyono H
Vaccine; 2004 Sep; 22(27-28):3751-61. PubMed ID: 15315856
[TBL] [Abstract][Full Text] [Related]
16. ADP-ribosylating bacterial enzymes for the targeted control of mucosal tolerance and immunity.
Lycke N
Ann N Y Acad Sci; 2004 Dec; 1029():193-208. PubMed ID: 15681758
[TBL] [Abstract][Full Text] [Related]
17. Involvement of dendritic cell subsets in the induction of oral tolerance and immunity.
Fleeton M; Contractor N; Leon F; He J; Wetzel D; Dermody T; Iwasaki A; Kelsall B
Ann N Y Acad Sci; 2004 Dec; 1029():60-5. PubMed ID: 15681744
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of intestinal Peyer's patch interferon-alpha producing (plasmacytoid) dendritic cells.
Castellaneta A; Abe M; Morelli AE; Thomson AW
Hum Immunol; 2004 Feb; 65(2):104-13. PubMed ID: 14969765
[TBL] [Abstract][Full Text] [Related]
19. Extinction of IL-12 signaling promotes Fas-mediated apoptosis of antigen-specific T cells.
Marth T; Zeitz M; Ludviksson BR; Strober W; Kelsall BL
J Immunol; 1999 Jun; 162(12):7233-40. PubMed ID: 10358170
[TBL] [Abstract][Full Text] [Related]
20. Synergistic action of fms-like tyrosine kinase 3 ligand and CD40 ligand in the induction of dendritic cells and generation of antitumor immunity in vivo.
Borges L; Miller RE; Jones J; Ariail K; Whitmore J; Fanslow W; Lynch DH
J Immunol; 1999 Aug; 163(3):1289-97. PubMed ID: 10415026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]